Article Text

other Versions

PDF
Effect Of Drug Combinations On Admission For Recurrent Myocardial Infarction
  1. Menno E van der Elst (m.e.vanderelst{at}pharm.uu.nl)
  1. Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Netherlands
    1. Marcel L Bouvy (m.bouvy{at}pharm.uu.nl)
    1. SIR Institute for Pharmacy Practice and Policy, Netherlands
      1. Cornelis J de Blaey (c.j.de.blaey{at}winap.nl)
      1. Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Netherlands
        1. Anthonius de Boer (a.deboer{at}pharm.uu.nl)
        1. Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Netherlands

          Abstract

          Objective To determine the effect of the number of different drugs with a compliance of at least 70% on recurrent admission for myocardial infarction (MI) in patients with a history of MI.

          Design Nested case control study in a dynamic cohort.

          Setting PHARMO database that contains pharmacy dispensing records and hospital discharge records on 350,000 Dutch citizens.

          Subjects All patients hospitalised for first MI (ICD-9 410) from 1991 to 2000 with at least a 30-day survival after hospitalisation. Cases were admitted for recurrent MI and were matched for age, sex, and year of admission to controls that did not have a recurrent MI.

          Main outcome measure(s) Odds ratio with 95% CI for admission for recurrent MI. Exposure was the number of preventive drugs (antiplatelet agents, statins and beta-blockers or ACE inhibitors) used for at least 70% of the time.

          Results 389 cases were matched to 2,344 controls. The use of one drug was associated with a 7% odds reduction (95% CI 31% reduction to 26% increase) for admission for recurrent MI. The use of two or three drugs was associated with reductions of 24 and 38% (45% reduction to 6% increase and 3% to 61% reduction respectively). Addition of one drug caused a 14% reduction (2% to 25%).

          Conclusions Multiple drug treatment decreases admissions for recurrent MI in patients with a history of MI. Every addition of a drug, regardless of drug class, reduces the risk even further. These results support the treatment strategies as applied in daily practice.

          Statistics from Altmetric.com

          Request permissions

          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.